Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Thyrospheres from B-CPAP Cell Line with BRAF and TERT Promoter Mutations have Different Functional and Molecular Features than Parental Cells.

Caria P, Pillai R, Dettori T, Frau DV, Zavattari P, Riva G, Romano G, Pani F, Bentivegna A, Giovannoni R, Pagni F, Sogos V, Vanni R.

J Cancer. 2017 Jun 3;8(9):1629-1639. doi: 10.7150/jca.18855. eCollection 2017.

2.

Expression of p63 and Bcl-2 in Malignant Thyroid Tumors and their Correlation with other Diagnostic Immunocytochemical Markers.

Gupta A, Jain S, Khurana N, Kakar AK.

J Clin Diagn Res. 2016 Jul;10(7):EC04-8. doi: 10.7860/JCDR/2016/13899.8157. Epub 2016 Jul 1.

3.

On the Origin of Cells and Derivation of Thyroid Cancer: C Cell Story Revisited.

Nilsson M, Williams D.

Eur Thyroid J. 2016 Jul;5(2):79-93. doi: 10.1159/000447333. Epub 2016 Jun 24. Review.

4.

Thyroid regeneration: how stem cells play a role?

Kimura S.

Front Endocrinol (Lausanne). 2014 Apr 14;5:55. doi: 10.3389/fendo.2014.00055. eCollection 2014. Review.

5.

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.

Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R, Almeida A, Salgado C, Eloy C, Castro P, Prazeres H, Lima J, Amaro T, Lobo C, Martins MJ, Moura M, Cavaco B, Leite V, Cameselle-Teijeiro JM, Carrilho F, Carvalheiro M, Máximo V, Sobrinho-Simões M, Soares P.

J Clin Endocrinol Metab. 2014 May;99(5):E754-65. doi: 10.1210/jc.2013-3734. Epub 2014 Jan 29.

6.

Stem cell antigen 1-positive mesenchymal cells are the origin of follicular cells during thyroid regeneration.

Okamoto M, Hayase S, Miyakoshi M, Murata T, Kimura S.

PLoS One. 2013 Nov 21;8(11):e80801. doi: 10.1371/journal.pone.0080801. eCollection 2013.

7.

Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas.

Soares P, Lima J, Preto A, Castro P, Vinagre J, Celestino R, Couto JP, Prazeres H, Eloy C, Máximo V, Sobrinho-Simões M.

Curr Genomics. 2011 Dec;12(8):609-17. doi: 10.2174/138920211798120853.

8.

Clinical review: The emerging cell biology of thyroid stem cells.

Davies TF, Latif R, Minsky NC, Ma R.

J Clin Endocrinol Metab. 2011 Sep;96(9):2692-702. doi: 10.1210/jc.2011-1047. Epub 2011 Jul 21. Review.

9.

Dedifferentiation of human primary thyrocytes into multilineage progenitor cells without gene introduction.

Suzuki K, Mitsutake N, Saenko V, Suzuki M, Matsuse M, Ohtsuru A, Kumagai A, Uga T, Yano H, Nagayama Y, Yamashita S.

PLoS One. 2011 Apr 27;6(4):e19354. doi: 10.1371/journal.pone.0019354.

10.

Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer.

Cunha LL, Ferreira RC, Marcello MA, Vassallo J, Ward LS.

J Thyroid Res. 2011 Feb 17;2011:387062. doi: 10.4061/2011/387062.

11.

Inmunohistochemical profile of solid cell nest of thyroid gland.

Ríos Moreno MJ, Galera-Ruiz H, De Miguel M, López MI, Illanes M, Galera-Davidson H.

Endocr Pathol. 2011 Mar;22(1):35-9. doi: 10.1007/s12022-010-9145-4.

12.

Development of thyroid gland and ultimobranchial body cyst is independent of p63.

Ozaki T, Nagashima K, Kusakabe T, Kakudo K, Kimura S.

Lab Invest. 2011 Jan;91(1):138-46. doi: 10.1038/labinvest.2010.137. Epub 2010 Aug 9.

13.

Thyroid stem cells: lessons from normal development and thyroid cancer.

Thomas D, Friedman S, Lin RY.

Endocr Relat Cancer. 2008 Mar;15(1):51-8. doi: 10.1677/ERC-07-0210. Review.

Supplemental Content

Support Center